Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (6731)	7/19/1998 9:26:00 PM
From: Robert K.	Read Replies (1) \| Respond to of 17367

I think its the strength of the xoma patents that brought the deal it did. Basically incy gets almost nothing if bpi doesnt pan out. If it does pan out incy will share in the profits that they otherwise couldnt get. Xoma locks out the competition for virtually no risk. Xoma also gets freedom of expression and development without apparent threat of lawsuit. Still havent read the edgar, but I will. Oh yeah, no overhang now from potential bpi partners. Good deal xoma. What I wanted all along. Good timing too, pre-september